Sareum Holdings (SAR)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 15.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 45.20
  • 52 Week Low: 11.25
  • Currency: UK Pounds
  • Shares Issued: 134.41m
  • Volume: 56,646
  • Market Cap: £20.16m
  • RiskGrade: 594
  • Beta: 0.01

Latest ShareCast News

Sareum shares drop on product licence termination

By Benjamin Chiou

Date: Tuesday 31 Dec 2024

(Sharecast News) - Autoimmune disease and cancer treatment developer Sareum has revealed that the commercial licence of its jointly developed SRA737 product has been terminated by a biopharma company in the US.

Sareum shares rise on China patent allowance

By Josh White

Date: Monday 16 Sep 2024

(Sharecast News) - Cambridge-based biotechnology firm Sareum Holdings announced on Monday that it has received a notice of allowance from the China National Intellectual Property Administration for its patent application concerning crystalline forms of SDC-1801.

Sareum announces positive results from kinase inhibitor trial

By Josh White

Date: Monday 01 Jul 2024

(Sharecast News) - Sareum Holdings announced positive topline results from its phase 1a clinical trial of SDC-1801, a dual TYK2/JAK1 kinase inhibitor under development for treating autoimmune diseases.

Sareum allowed European patent for primary kinas... 15-Mar-2024 ShareCast
Sareum reports positive progress in psoriasis pr... 15-Feb-2024 ShareCast
Sareum shares jump on cancer drug licensing deal 02-Jan-2024 ShareCast
Sareum secures Japan patent for kinase inhibitor... 03-Nov-2023 ShareCast
Sareum losses widen as clinical trials continue 09-Oct-2023 ShareCast
Director dealings: Blackbird, Sareum insiders pi... 06-Sep-2023 ShareCast
Sareum granted new patents in China, US 26-Jun-2023 ShareCast
Sareum gets approval for phase one psoriasis stu... 05-May-2023 ShareCast
Sareum looks at options as GSK division returns ... 06-Mar-2023 ShareCast
Sareum confident despite recent setbacks 16-Dec-2022 ShareCast
Sareum progresses Covid-19 and autoimmune treatm... 16-Mar-2022 ShareCast
Sareum expects FY losses to widen on higher R&D ... 19-Aug-2021 ShareCast
Sareum positive on SRA737 outlook after Sierra c... 06-Aug-2021 ShareCast
Sareum releases 'encouraging' results from Covid... 01-Jul-2021 ShareCast
Sareum's pre-clinical development of SDC-1801 de... 25-May-2021 ShareCast
Sareum gets approval for US patent application 07-Jan-2021 ShareCast
Sareum Holdings secures grant for Covid-19 treat... 03-Dec-2020 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Sareum Holdings Market Data

Currency UK Pounds
Share Price 15.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 45.20
52 Week Low 11.25
Volume 56,646
Shares Issued 134.41m
Market Cap £20.16m
Beta 0.01
RiskGrade 594

Sareum Holdings Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
45.71% below the market average45.71% below the market average45.71% below the market average45.71% below the market average45.71% below the market average
2.13% below the sector average2.13% below the sector average2.13% below the sector average2.13% below the sector average2.13% below the sector average
Price Trend
91.34% below the market average91.34% below the market average91.34% below the market average91.34% below the market average91.34% below the market average
70.21% below the sector average70.21% below the sector average70.21% below the sector average70.21% below the sector average70.21% below the sector average
Income Not Available
Growth Not Available

Sareum Holdings Dividends

No dividends found

Trades for 29-May-2025

Time Volume / Share Price
08:03 17,137 @ 14.04p
08:02 8,805 @ 15.40p
08:02 17,761 @ 14.11p
08:01 6,467 @ 15.40p
08:00 6,476 @ 16.00p

Sareum Holdings Key Personnel

COO Timothy J Mitchell

Top of Page